Cite
HARVARD Citation
LeWitt, P. et al. (2019). Safety and efficacy of CVT-301 (levodopa inhalation powder) on motor function during off periods in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled phase 3 trial. Lancet neurology. 18 (2), pp. 145-154. [Online].